Recent News

Drug Companies Join Medical Psychedelic Movement—but Without the High

The Wall Street Journal

December 18, 2022

Filament CSO Ryan Moss spoke to the Wall Street Journal about our development of standardized drug candidates made from psychedelics like magic mushrooms and ayahuasca.

Visit:
Drug Companies Join Medical Psychedelic Movement—but Without the High
Read the full article

read more News